biliary tract benign neoplasm

ICD-10 Codes

Related ICD-10:

Description

Based on the provided context, here's a description of biliary tract benign neoplasms:

Types and Characteristics

  • Benign tumors of the biliary passages are rare and seldom considered in the differential diagnosis of obstructive jaundice [3].
  • Non-cancerous (benign) tumors can also grow in the bile ducts, including bile duct adenomas [8].
  • IPNB (Intraductal Papillary Neoplasms of the Bile Duct) is an uncommon benign extra-hepatic bile duct tumor, characterized by papillary or villous growth within the bile duct lumen [9].

Clinical Features

  • Benign strictures occur after cholecystectomy or distal gastric surgery, are short and cause smooth, symmetric narrowing of the common hepatic bile duct [2].
  • Benign adenomas or papillomas are exceedingly rare in comparison with malignant tumors. Even benign tumors tend to recur after excision and have a potential for malignancy [4].

Comparison with Malignant Tumors

  • Bile duct cancer (cholangiocarcinoma) is a type of cancer that starts in a bile duct, which can start in any part of the bile duct system [5].
  • Gallbladder polyps are usually asymptomatic benign mucosal projections that develop in the lumen of the gallbladder, most are < 10 mm in diameter and composed of mucosa [6].

References

[1] Sarcognato et al. (2021) - Grossly, IPNB appears as a visible papillary, villous, or polypoid, red-colored, soft mass, predominantly growing in a dilated bile duct lumen...

[2] Gore et al. (2007) - Benign strictures occur after cholecystectomy or distal gastric surgery, are short and cause smooth, symmetric narrowing of the common hepatic bile duct.

[3] Moore et al. (1952) - Benign tumors of the biliary passages are rare and are seldom considered in the differential diagnosis of obstructive jaundice.

[4] Apr 4, 2024 - Benign adenomas or papillomas are exceedingly rare in comparison with malignant tumors.

[5] Oct 11, 2024 - Bile duct cancer (also known as cholangiocarcinoma) is a type of cancer that starts in a bile duct.

[6] Gallbladder polyps are usually asymptomatic benign mucosal projections that develop in the lumen of the gallbladder.

[7] Barber et al. (1960) - Benign neoplasms of the extrahepatic bile ducts or the papilla of Vater are an infrequent cause of biliary obstruction.

[8] Non cancerous bile duct tumours. Non cancerous (benign) tumours can also grow in the bile ducts, including bile duct adenomas.

[9] Shah et al. (2021) - IPNB is an uncommon benign extra-hepatic bile duct tumor, characterized by papillary or villous growth within the bile duct lumen.

Additional Characteristics

  • bile duct adenomas
  • benign strictures
  • intraductal papillary neoplasms of the bile duct (IPNB)
  • benign adenomas or papillomas
  • bile duct cancer (cholangiocarcinoma)
  • gallbladder polyps

Signs and Symptoms

Based on the provided context, here are the signs and symptoms of biliary tract benign neoplasm:

  • Jaundice (yellowing of the skin or whites of the eyes) [1]
  • Abdominal pain, mostly in the upper right part of the belly [7]
  • Belly bloating [7]
  • A mass you can feel through the skin [7]
  • Losing weight without trying [7]
  • Itching [3]
  • Light-colored/greasy stools [1]
  • Dark urine [1]

It's worth noting that these symptoms may be similar to those of biliary tract cancer, but the presence of a benign neoplasm would not typically cause significant weight loss or a palpable mass.

References: [1] Oct 11, 2024 — Signs and Symptoms of Bile Duct Cancer [3] Worsening jaundice (yellowish discoloration of the skin and whites of the eyes) · Abdominal discomfort · Loss of appetite · Weight loss · Itchiness. [7] Jul 31, 2024 — Belly pain, mostly in the upper right part of the belly. · Belly bloating. · A mass you can feel through the skin. · Losing weight without trying.

Additional Symptoms

Diagnostic Tests

Diagnostic Tests for Biliary Tract Benign Neoplasms

Biliary tract benign neoplasms, also known as bile duct tumors, can be diagnosed using various imaging and laboratory tests.

  • Ultrasound: Ultrasonography (US) of the liver is often the first-line investigation in patients with obstructive jaundice. US typically reveals dilated intrahepatic biliary radicals and a hypoechoic mass in the gallbladder or bile ducts [14].
  • Computed Tomography (CT) scans: CT scans can help identify the location, size, and extent of the tumor, as well as any potential complications such as jaundice or pancreatitis [10].
  • Magnetic Resonance Imaging (MRI): MRI scans may be able to distinguish between benign and malignant tumors. MRIs may also reveal the relationship between the tumor and surrounding structures [13].
  • Magnetic Resonance Cholangiopancreatography (MRCP): MRCP is a non-invasive imaging technique that can provide detailed images of the bile ducts and gallbladder, helping to identify tumors or other abnormalities.
  • Endoscopic Ultrasonography (EUS): EUS is a minimally invasive procedure that uses an endoscope with a built-in ultrasound probe to visualize the bile ducts and surrounding tissues.

Laboratory Tests

In addition to imaging tests, laboratory tests may be performed to confirm the diagnosis of biliary tract benign neoplasms. These include:

  • Blood tests: Blood tests can help identify any abnormalities in liver function or other biomarkers associated with bile duct tumors.
  • Imaging-guided biopsies: Imaging-guided biopsies may be performed to obtain tissue samples for histological examination and confirm the diagnosis.

References

[10] RM Gore, et al. (2007). Ultrasound, CT, and MR are the primary means of non-invasively diagnosing and staging cholangiocarcinoma. Cited by 59.

[13] Jun 3, 2022. MRI: Magnetic resonance imaging scans may be able to distinguish between benign and malignant tumors.

[14] Apr 4, 2024. Ultrasonography (US) of the liver is the investigation of first choice in patients with obstructive jaundice.

Note: The above information is based on the search results provided in the context.

Additional Diagnostic Tests

  • Blood tests
  • Magnetic Resonance Imaging (MRI)
  • Ultrasound
  • Computed Tomography (CT) scans
  • Magnetic Resonance Cholangiopancreatography (MRCP)
  • Endoscopic Ultrasonography (EUS)
  • Imaging-guided biopsies

Treatment

Treatment Options for Biliary Tract Benign Neoplasms

Biliary tract benign neoplasms, also known as bile duct tumors, are rare and can be challenging to treat. While surgery is often the primary treatment option, drug therapy may also play a role in managing these conditions.

  • Chemotherapy: Chemotherapy may be used to treat biliary tract cancer, but its effectiveness in treating benign neop

Recommended Medications

  • Chemotherapy

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Biliary Tract Benign Neoplasms

The differential diagnosis of biliary tract benign neoplasms is a crucial aspect of diagnosing and treating various conditions affecting the bile ducts. According to medical literature, the main differential diagnoses for simple bile duct or peribiliary gland cysts, developmental cysts, hydatid cysts, microcystic serous cystadenomas, and other benign neoplasms include:

  • Simple bile duct or peribiliary gland cysts: These are the most common type of biliary tract cysts and can be easily distinguished from other types of cysts based on their location and characteristics.
  • Developmental cysts: Also known as choledochal cysts, these are congenital anomalies that can cause obstruction and infection in the bile ducts.
  • Hydatid cysts: These are parasitic cysts caused by Echinococcus granulosus and can be found in the liver or other organs, including the biliary tract.
  • Microcystic serous cystadenomas: These are rare, benign tumors that can cause obstruction and pain in the bile ducts.

Key Points to Consider

  • The differential diagnosis of biliary tract benign neoplasms is a complex process that requires careful consideration of various factors, including patient history, physical examination, imaging studies, and laboratory tests.
  • Simple bile duct or peribiliary gland cysts are the most common type of biliary tract cysts and can be easily distinguished from other types of cysts based on their location and characteristics.
  • Developmental cysts, hydatid cysts, microcystic serous cystadenomas, and other benign neoplasms must be considered in the differential diagnosis of biliary tract conditions.

References

[1] Sarcognato et al. (2021) - The main differential diagnoses include simple bile duct or peribiliary gland cysts, developmental cysts, hydatid cysts, microcystic serous cystadenomas, and other benign neoplasms. [2] Gore et al. (2007) - Most biliary tract neoplasms are malignant and have been traditionally divided into cancers of the gallbladder, the extrahepatic bile ducts, and ampulla of Vater. [3] Moore et al. (1952) - Benign tumors of the biliary passages are rare and

Additional Differential Diagnoses

  • Simple bile duct or peribiliary gland cysts
  • Developmental cysts
  • Hydatid cysts
  • Microcystic serous cystadenomas

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_663
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_9741
owl#annotatedSource
t332784
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0050625
core#notation
DOID:0050625
oboInOwl#hasAlternativeId
DOID:4609
oboInOwl#hasDbXref
UMLS_CUI:C0345913
IAO_0000115
A hepatobiliary benign neoplasm located_in the biliary tract.
rdf-schema#label
biliary tract benign neoplasm
oboInOwl#hasExactSynonym
tumor of the extrahepatic bile duct
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
relatedICD
http://example.org/icd10/K82.3
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
owl#equivalentClass
t332019

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.